IHE

Fund Description
The iShares Dow Jones U.S. Pharmaceuticals Index Fund seeks investment results that correspond generally to the price and yield performance before fees and expenses of the Dow Jones U.S. Select Pharmaceuticals Index.
Fund Profile
Fund Name iShares US Pharmaceuticals ETF
Fund Exchange Ticker IHE
Fund Sponsor Blackrock (iShares)
Fund ISIN US4642888360
Net Expense Ratio 0.42 %
Fund Inception Date 1 May 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Dow Jones US Select Pharmaceuticals Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 21 January 2020
Asset Under Management 362.35 Million (USD)
1 Month Total Return 4.70 %
Year To Date Return 2.78 %
1 Year Total Return 13.28 %
3 Year Annualized Total Return 6.15 %
NAV 164.705
Share Outstanding 2,200,000
Top 10 Holdings (17 January 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
JOHNSON & JOHNSON JNJ EQUI 0.2209000000
MERCK & CO. INC. MRK EQUI 0.1867000000
ELI LILLY & CO LLY EQUI 0.0483000000
ZOETIS INC ZTS EQUI 0.0474000000
BRISTOL-MYERS SQUIBB CO BMY EQUI 0.0447000000
PFIZER INC PFE EQUI 0.0443000000
ALLERGAN PLC AGN EQUI 0.0431000000
ELANCO ANIMAL HEALTH INC ELAN EQUI 0.0427000000
MYLAN NV MYL EQUI 0.0427000000
CATALENT INC CTLT EQUI 0.0340000000